INTERNATIONAL FLAVORS & FRAGRANCES INC Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2026-09: Study NCT07413744; Company role Collaborator; Phase Phase 1; Status Recruiting.
- 2020-11-02: Study NCT05177978; Company role Collaborator; Phase Not applicable; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2026-09 | NCT07413744 The Gut - PRO Study | Collaborator Lead: University of Wisconsin, Madison | Phase 1 | Recruiting | Alzheimer Disease | 40 | 2029-09 |
| 2020-11-02 | NCT05177978 The Cognitive Effects of 6- and 12-weeks Administration of a Food Supplement Containing Phosphatidylserine in Healthy Children Aged 8 to 12 Years | Collaborator Lead: Northumbria University | Not applicable | Completed | Cognitive Change | 208 | 2022-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LyondellBasell Industries N.V. (LYB) | $19.447B | -49.15 | |
| WESTLAKE CORP (WLK) | United States | $8.528B | |
| NEWMARKET CORP (NEU) | United States | $8.222B | 16.78 |
| SENSIENT TECHNOLOGIES CORP (SXT) | United States | $5.455B | 33.22 |
| REX AMERICAN RESOURCES Corp (REX) | United States | $1.437B | 10.31 |
| Green Plains Inc. (GPRE) | United States | $1.054B | 8.70 |
| Westlake Chemical Partners LP (WLKP) | United States | $0.754B | 2.35 |
| Gevo, Inc. (GEVO) | United States | $0.345B | -1.72 |
| Alto Ingredients, Inc. (ALTO) | United States | $0.289B | 8.52 |
| FutureFuel Corp. (FF) | United States | $0.225B | -6.53 |